ProteoNova, Inc.
Records under this name other than the patents ProteoNova, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 6 of 6 · Back to ProteoNova, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,920,453 | Generation of library of soluble random polypeptides linked to mRNA Lapsed on the fee record Ended Mar 20, 2026 · From the USPTO record | Lapsed on the fee record | Ended Mar 20, 2026 | From the USPTO record |
| US 9,193,795 | Method for making targeted therapeutic agents Term ended Term ended Jan 12, 2026 · From the USPTO record | Term ended | Term ended Jan 12, 2026 | From the USPTO record |
| US 6,962,781 | In vitro evolution of nucleic acids and encoded polypeptide Term ended Term ended Sep 20, 2022 · From the USPTO record | Term ended | Term ended Sep 20, 2022 | From the USPTO record |
| US 7,488,600 | Compositions and methods for the identification and selection of nucleic acids and polypeptides Lapsed on the fee record Ended Feb 10, 2021 · From the USPTO record | Lapsed on the fee record | Ended Feb 10, 2021 | From the USPTO record |
| US 7,410,761 | System for rapid identification and selection of nucleic acids and polypeptides, and method thereof Lapsed on the fee record Ended Aug 12, 2020 · From the USPTO record | Lapsed on the fee record | Ended Aug 12, 2020 | From the USPTO record |
| US 7,351,812 | In vitro evolution of nucleic acids and encoded polypeptide Lapsed on the fee record Ended Apr 1, 2020 · From the USPTO record | Lapsed on the fee record | Ended Apr 1, 2020 | From the USPTO record |